Evaluation of Cefazolin in the Treatment of Bacterial Endocarditis and Bacteremia

Abstract
Seven patients with bacterial endocarditis and two patients with bacteremia were treated with cefazolin, with excellent bacteriologic and good clinical response. Dosage of cefazolin was 4–12 g daily. Large doses of cefazolin (12 g/day) were tolerated well by these patients without evidence of hematotoxicity, hepatotoxicity, or nephrotoxicity. Cefazolin is an effective antimicrobial agent for treatment of serious infections caused by susceptible gram-positive organisms.

This publication has 0 references indexed in Scilit: